EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Host tyrosine kinase signaling and tyrosine kinase inhibitors as candidate host-directed therapies for tuberculosis

Xiaolin Xing, Haohan Liu, Yu Pang, Shanshan Li

Microbial Pathogenesis · 2026-12 · 221 · 108850

DOI: 10.1016/j.micpath.2026.108850 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026-12. Verfasst von Xiaolin Xing und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bacteriology and Immunology, Beijing Key Laboratory for Key Technologies in Tuberculosis Prevention and Control, Beijing Chest Hospital…. Hauptthemen laut MEDLINE: Host-Directed Therapy, Protein-Tyrosine Kinases, Signal Transduction, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Nova Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Host-Directed TherapyProtein-Tyrosine KinasesSignal TransductionProtein Kinase InhibitorsMycobacterium tuberculosisTuberculosisAntitubercular AgentsHost-Pathogen InteractionsHumansAnimalsTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

Host-directed therapy (HDT)Mycobacterium tuberculosis (Mtb)Tyrosine kinase inhibitors (TKIs)Tyrosine kinases (PTKs)

Substanzen

Protein-Tyrosine KinasesProtein Kinase InhibitorsAntitubercular AgentsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Bacteriology and Immunology, Beijing Key Laboratory for Key Technologies in Tuberculosis Prevention and Control, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor…

Förderung

  • National Natural Science Foundation of China
  • Beijing Nova Program

Zitieren

APA

Xing, X., Liu, H., Pang, Y., & Li, S. (2026). Host tyrosine kinase signaling and tyrosine kinase inhibitors as candidate host-directed therapies for tuberculosis. Microbial Pathogenesis, 221, 108850. https://doi.org/10.1016/j.micpath.2026.108850

Vancouver

Xing X, Liu H, Pang Y, Li S. Host tyrosine kinase signaling and tyrosine kinase inhibitors as candidate host-directed therapies for tuberculosis. Microbial Pathogenesis. 2026;221:108850. doi:10.1016/j.micpath.2026.108850

BibTeX
@article{Xing2026,
  author = {Xing, Xiaolin and Liu, Haohan and Pang, Yu and Li, Shanshan},
  title = {Host tyrosine kinase signaling and tyrosine kinase inhibitors as candidate host-directed therapies for tuberculosis},
  journal = {Microbial Pathogenesis},
  year = {2026},
  volume = {221},
  pages = {108850},
  doi = {10.1016/j.micpath.2026.108850}
}
Kostenlos starten →